It was reported that EF2 was highly expressed in lung adenocarcinoma and it was positively correlated with a significantly higher incidence of tumor recurrence and increased cisplatin resistance, which ultimately reflected in a worse prognosis [19]. Here, EEF2 is linked to neoplasm.